RCKT icon

Rocket Pharmaceuticals

195 hedge funds and large institutions have $233M invested in Rocket Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 81 increasing their positions, 47 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

48% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 79

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

68% less capital invested

Capital invested by funds: $722M → $233M (-$489M)

Holders
195
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.71M
Puts
$1.22M
Net Calls
Net Calls Change

Top Buyers

1 +$16M
2 +$11.6M
3 +$10.1M
4
Two Sigma Investments
Two Sigma Investments
New York
+$8.74M
5
Millennium Management
Millennium Management
New York
+$8.11M

Top Sellers

1 -$84.2M
2 -$32.2M
3 -$16.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$9.85M
5
State Street
State Street
Massachusetts
-$8.93M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$659K
52
$652K
53
$652K
54
$647K
55
$584K
56
$580K
57
$568K
58
$556K
59
$525K
60
$503K
61
$470K
62
$452K
63
$441K
64
$430K
65
$429K
66
$427K
67
$404K
68
$382K
69
$377K
70
$377K
71
$373K
72
$363K
73
$329K
74
$323K
75
$301K